Omni Partners US’s Spectral AI MDAI Stock Holding History

Omni Partners US’s Portfolio MDAI Stock Details MDAI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$5.12M	Buy	527,687 +8,486	+2%	+$82.2K	0.26%	70
2021 Q2	$5.04M	Buy	+519,201	New	+$5.04M	0.22%	45

Other funds holding MDAI

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

SCM

Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

FTCM

Fir Tree Capital Management New York $21.8M AUM 1.61% 1-Year Est. Return

Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

PAMP

Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Omni Partners US's MDAI Position: Q3 2021 in Review

Omni Partners US increased its Spectral AI (MDAI) stake by 1.6% in Q3 2021, buying an estimated $82.2K and bringing the position to 527,687 shares worth $5.12M. The position accounts for 0.26% of the portfolio, ranked #70.

Omni Partners US first reported a position in MDAI in Q2 2021 and has held it in 2 quarters since. 64 funds tracked by Wall St. Rank hold MDAI as of Q3 2021.

Omni Partners US held 527,687 shares of Spectral AI worth $5.12M as of Q3 2021.
Omni Partners US bought 8,486 Spectral AI shares in Q3 2021, an estimated $82.2K.
Spectral AI made up 0.26% of Omni Partners US's portfolio in Q3 2021, its #70 holding.
Omni Partners US first reported a position in Spectral AI in Q2 2021 and has held it in 2 quarters since.
64 funds tracked by Wall St. Rank held Spectral AI as of Q3 2021.

Based on Omni Partners US's 13F filing for Q3 2021, filed 15 Nov 2021.